Dreampath Diagnostics
Pablo Jordan is the CEO of Dreampath Diagnostics, a global leader in workflow automation and traceability in pathology. With a background in business development, strategic alliances, and international business development, Pablo has held various leadership roles in companies such as Biodoxis, EPEMED, GSK, Definiens, bioMerieux, bioTheranostics, Roche Diagnostics, Ventana Medical Systems, and Merck Millipore. Pablo holds a Master's degree in International Economy and has a strong educational background from various universities.
This person is not in any offices
Dreampath Diagnostics
Industry leaders in patient sample management and traceability. Improving patient safety and AP lab workflow by advancing sample chain-of-custody. #patientsafety The Dreampath portfolio is built upon: -The importance patient safety and advancing it through proper chain-of-custody for patient samples in the anatomic pathology (AP) lab -The need for robust, reliable, and accurate access to samples in the AP lab (both clinical and research environments) -Fina, Crystal and Hydra track and monitor patient samples in the laboratory workflow, from receipt to diagnosis www.dreampathdx.net YouTube: @DreampathDiagnostics Twitter: @DreampathDx